Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOLNUPIRAVIR vs MONTELUKAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOLNUPIRAVIR vs MONTELUKAST: Safety Overview

Metric MOLNUPIRAVIR MONTELUKAST
Total FAERS Reports 4,788 26,982
Deaths Reported 424 873
Death Rate 8.9% 3.2%
Hospitalizations 802 7,555
Average Patient Age 71.1 yrs 45.9 yrs
% Female Patients 54.9% 65.2%
FDA Approval Date N/A Apr 18, 2017
Manufacturer Merck Sharp & Dohme LLC Macleods Pharmaceuticals Limited
Route ORAL ORAL
Marketing Status N/A Prescription